CBO Says Pay To Delay Bill Can Save $4.8 Billion
November 9, 2011
Pharmalot
By Ed Silverman
A bipartisan bill that would limit pay-to-delay settlements, which are designed to keep lower-cost generic drugs off the market for extended periods, would save taxpayers an estimated $4.8 billion over the next decade, according to a new report from the Congressional Budget Office. Read more
